MCE123 Logo

This website uses Cookies, and by using the website, you accept our Terms of Service, Privacy Policy, and other applicable policies set by our Legal Department.

You agree to stay up to date on any changes to our legal policies, as they are posted, by visiting our Legal Department. For your viewing convenience, we are not required to notify you again.

MCE123 - Technology Development

Genetic Modifying Medication to Remove Specific Allergies

Genetic Modifying Medication to Remove Specific Allergies

A new type of medication that could be developed would be a genetic modifying medication that removes a person’s allergies, such as allergies to peanuts, or animals, or other types of allergies. The reason that this medication is so important to develop is because it could save a lot of lives from dying due to allergic reactions. This medication is possible with current inventions of medications such as Aimovig, Ajovy and Emgality, which target or bind to the CGRP (calcitonin-gene-related peptide) protein. If researches can find a similar neurotransmitter for specific allergies within our genes, it is entirely possible to develop a medication that could suppress that allergy. This would mean that millions of allergy sufferers would no longer need to be connected at the hip to their Epipen.

Intellectual Property Rights Management

This Intellectual Property is owned by MCE123 Technology Development. By viewing and/or using this Intellectual Property, you agree to the rights of the IP holder established under the Intellectual Property Rights Management agreement. Protection Status Site Protected by SiteLock